Quarterly report [Sections 13 or 15(d)]

Intangible Asset, Net - Additional Information (Details)

v3.25.2
Intangible Asset, Net - Additional Information (Details) - USD ($)
$ in Thousands
6 Months Ended
Oct. 25, 2024
Jun. 30, 2025
Jun. 30, 2024
Nov. 18, 2015
Intangible Assets Net Excluding Goodwill [Line Items]        
Amortization of intangible asset   $ 687 $ 0  
Pfizer License Agreement        
Intangible Assets Net Excluding Goodwill [Line Items]        
Regulatory milestone payments upon approval of product       $ 20,000
Regulatory milestone payment amortization period 14 years 4 months 24 days